These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3671452)

  • 21. [Studies on analysis of pharmaceutical preparations. XI. Spectrophotometric determination of phenacetin in pharmaceutical preparations].
    Tatsuzawa M; Hashiba S
    Eisei Shikenjo Hokoku; 1968; 86():84-6. PubMed ID: 5753694
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on analysis of pharmaceutical preparations. X. Spectrophotometric determination of nicotinoyl-4-aminoantipyrine in pharmaceutical preparations].
    Tatsuzawa M; Hashiba S; Murata M
    Eisei Shikenjo Hokoku; 1968; 86():8-12. PubMed ID: 5753697
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of buffer effect in qualitative analyses of pharmaceutical products. I].
    Paál T
    Acta Pharm Hung; 1972 Jan; 42(1):32-42. PubMed ID: 5019406
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular galenical evaluation of the conventional handling of solids in homeopathy].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 Feb; 40(2):129-30. PubMed ID: 4001150
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of analytical chemistry in the pharmacy of the 21st Century].
    Görög S
    Acta Pharm Hung; 2001 Oct; 71(3):337-43. PubMed ID: 11961903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemical equivalency and therapeutic non-equivalency of drugs in pharmaceutical forms of different formulation].
    Borasi M
    Boll Chim Farm; 1973 Jan; 112(1):1-5. PubMed ID: 4710257
    [No Abstract]   [Full Text] [Related]  

  • 28. Near infrared reflectance analysis: features and applications in pharmaceutical and biomedical analysis.
    Corti P; Dreassi E; Leonardi S
    Farmaco; 1993 Jan; 48(1):3-20. PubMed ID: 8457277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of interfacial characteristics in pharmaceutical technology].
    Dredán J; Csóka G; Marton S; Antal I
    Acta Pharm Hung; 2003; 73(3):147-51. PubMed ID: 15112437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral pulsatile delivery systems based on swellable hydrophilic polymers.
    Gazzaniga A; Palugan L; Foppoli A; Sangalli ME
    Eur J Pharm Biopharm; 2008 Jan; 68(1):11-8. PubMed ID: 17888641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liberation of the active ingredient from pharmaceutical microcapsules].
    Dévay A; Uderszky J; Rácz I
    Acta Pharm Hung; 1983 Jan; 53(1):28-35. PubMed ID: 6837317
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical analysis in a multidisciplinary development environment.
    Berridge JC
    J Pharm Pharmacol; 1993 Apr; 45 Suppl 1():361-6. PubMed ID: 8098744
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prospects of pharmaceutical analysis].
    Buriánek J; Stáhlavská A
    Cesk Farm; 1972 Feb; 21(1):3-6. PubMed ID: 5013317
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adsorption of cationic amphiphilic drugs to antacids and adsorbents. 5. The desorption behavior of cationic amphiphilic drugs].
    Thoma K; Lieb H
    Pharm Acta Helv; 1985; 60(4):98-105. PubMed ID: 4011626
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fluorimetric determination of vitamin K and P in drug associations].
    Veronese FM; Meani A; Boccù E
    Acta Vitaminol Enzymol; 1968; 22(6):203-8. PubMed ID: 5755991
    [No Abstract]   [Full Text] [Related]  

  • 36. [Matrices for controlled liberation of drugs from polymers. I. Mechanisms of the penetration of solvents into polymers].
    Gander B; Gurny R; Doelker E
    Pharm Acta Helv; 1986; 61(5-6):130-4. PubMed ID: 3725810
    [No Abstract]   [Full Text] [Related]  

  • 37. [The in vitro liberation behavior of quinidine from drug forms with prolonged release by various liberation methods].
    Appelt B; Hennig D; Wenzel U
    Pharmazie; 1986 Jan; 41(1):44-6. PubMed ID: 3960948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [X-ray diffraction applied to the study of the structure of pharmacologically active substances].
    Covello M; Silipo C; Vittoria A
    Boll Chim Farm; 1971 Apr; 110(4):183-96 contd. PubMed ID: 5111344
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of the polymerization-mixture composition for monolithic methacrylate-based columns on the electrochromatographic performance of drug molecules.
    Tanret I; Mangelings D; Vander Heyden Y
    J Pharm Biomed Anal; 2008 Sep; 48(2):264-77. PubMed ID: 18182267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.